Accelrys Inc. (Nasdaq: ACCL)

https://www.accelrys.com

Accelrys (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific foundation optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, QA/QC and manufacturing phases of product development. Accelrys offers capabilities in scientific data management, modeling and simulation, research informatics, laboratory informatics, enterprise quality management, environmental health & safety and operations intelligence for customers in science-driven industries. Using Accelrys technology, scientific innovators can access, organize, analyze and share data in unprecedented ways across the research, laboratory and manufacturing continuum, ultimately enhancing innovation, improving productivity and compliance, reducing costs and accelerating product development from research to manufacturing. Accelrys solutions are used by more than 2,000 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, CA. Accelrys employs more than 225 full-time PhD scientists. *

	Start	2004-05-03 splitoff
	End	2015-01-06 renamed before
	Group	Dassault Systèmes (3DS) (Group)
	Today	Biovia Corporation
	Predecessor	Accelrys Inc. (old, before 5/04)
	Successor	Biovia Corporation
	Industry	bioinformatics (biological software and databases)
	Industry 2	cheminformatics

	Region	San Diego, CA
	Country	United States (USA)
	Street	10188 Telesis Court Suite 100
	City	92121 San Diego, CA
	Tel	+1-858-799-5000
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	79,739,000 (revenue, consolidated (07/08)) 2008-03-31)
	Profit	1,321,000 (2008-03-31)
	Cash	76,382,000 (2008-03-31)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Dassault Systèmes (3DS) (Group)

[1] Dassault Systèmes S.A.. (6/12/19). "Press Release: Dassault Systèmes and Medidata Solutions to Join Forces to Accelerate the Life Sciences Industry Innovation for Patient-Centric Experience Through End-to-End Collaborative Platform". Vélizy-Villacoubla...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]